Regular price
$550.00
Sale price
$550.00
Regular price
Unit price
OFF
SpeedySwab™ Rapid COVID-19 + Flu A&B Test
A groundbreaking solution for the simultaneous detection of COVID-19, Influenza A, and Influenza B in just 15 minutes.
- 25 tests per box
- Detects: COVID-19 (SARS-CoV-2), Influenza A, and Influenza B.
- FDA Emergency Use Authorization (EUA) approved.
SpeedySwab™ is an FDA EUA authorized Rapid COVID-19, influenza A and Influenza B Antigen Self-Test designed for nasal application and is highly effective in detecting all COVID-19 variants and sub-variants with a class leading COVID-19 Clinical Sensitivity of 92.5%. The test uses the long-proven Lateral Flow Assay (LFA) technology. In three easy steps, simply swirl the soft tip of the nasal swab ½” – ¾” into each nostril for 15 seconds, insert the swab into a test tube with a buffer solution, and apply 4 drops onto the test card. Results will be available in 15 minutes.
- Specimen Type: Nasal Swab
- Result Time: 15 Minutes
- Reliable design supporting highly sensitive detection of Influenza A and B, and COVID-19 genetic variants and sub-variants.
- Simple format is designed for self-administration on adults, or by adults on children ages 2 and up for ease of use and provides results in 15 minutes.
- For ages: 2 years and older (with adult assistance for children).
- 25 Sterile Swabs
- 25 Test Tubes with Buffer Solution
- 25 Test Cards
- 2 Control Samples
- 5 Tube Holders
- 2 Instructions for Use (1 in English, 1 in Spanish)
The test uses lateral flow immunochromatographic technology to detect and differentiate between the antigens of COVID-19, Flu A, and Flu B from a nasal swab sample. Results are available in 15 minutes.
The test is intended for use by healthcare professionals for in-vitro diagnostic purposes. It is used for individuals showing symptoms of respiratory infections within the first five days of symptom onset.
The test has a shelf life of up to 18 months. Check the expiration date on the box before use.
The test has a clinical sensitivity of 92.6% for COVID-19, 82.9% for Flu A, and 90% for Flu B.
This test is authorized by the FDA under Emergency Use Authorization (EUA). It is not FDA approved or cleared, but it is authorized for the detection of SARS-CoV-2, influenza A, and influenza B.
Committed to providing innovative diagnostic testing devices.
Watmind USA is a leading healthcare biotechnology company committed to providing innovative diagnostic testing devices to U.S. consumers. Our mission is to improve healthcare outcomes by delivering reliable, fast, and accurate testing solutions. At the heart of this mission is our flagship brand, SpeedySwab™, which sets the standard for COVID-19 Flu A + B test innovation. By prioritizing accuracy, speed, and convenience, SpeedySwab™ ensures that individuals and healthcare providers have access to the most efficient at-home COVID flu test and COVID flu self-test options on the market.
Recently Viewed Products
About Watmind USA
Innovation, reliability, and user-centered care.
Watmind USA is a healthcare biotechnology company based in the United States. The company is focused on bringing innovative diagnostic testing devices to U.S. consumers to improve healthcare outcomes. Our flagship brand, SpeedySwab™ epitomizes accuracy, speed, and convenience, setting new industry standards in diagnostic testing. Watmind USA is a global provider of healthcare products whose core values are innovation, reliability, and user-centered care.
![Pharmalynk Online Store](https://cdn.shopify.com/s/files/1/1571/7313/files/logoblack.png?v=1613685254")
![pharmalynk.com](https://cdn.shopify.com/s/files/1/1571/7313/files/pharmalynkcom-01.svg?v=1725048346")
![Pharmalynk Online Store](https://cdn.shopify.com/s/files/1/1571/7313/files/5000web2_c8ac9667-e23f-49c8-9c99-b48dd89f7895.png?v=1728588520")